Skinvisible Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
SKVI
- Share Price
-
$0.18
- (As of Tuesday Closing)
Skinvisible Pharmaceuticals General Information
Description
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare, and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active.
Contact Information
Website
www.skinvisible.comCorporate Office
- 6320 South Sandhill Road
- Suite 10
- Las Vegas, NV 89120
- United States
Corporate Office
- 6320 South Sandhill Road
- Suite 10
- Las Vegas, NV 89120
- United States
Skinvisible Pharmaceuticals Stock Performance
As of 10-Nov-2026, Skinvisible Pharmaceuticals’s stock price is $0.18. Its current market cap is $973K with 5.4M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.18 | $0.18 | $0.15 - $0.54 | $973K | 5.4M | 1.42K | -$0.20 |
Skinvisible Pharmaceuticals Financials Summary
As of 30-Jun-2026, Skinvisible Pharmaceuticals has a trailing 12-month revenue of $20K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 6,943 | 7,014 | 7,864 | 6,516 |
| Revenue | 20 | 20 | 20 | 20 |
| EBITDA | (439) | (472) | 124 | (477) |
| Net Income | (1,031) | (1,064) | (566) | (2,382) |
| Total Assets | 123 | 128 | 158 | 163 |
| Total Debt | 5,863 | 5,734 | 5,724 | 6,153 |
Skinvisible Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Skinvisible Pharmaceuticals Patents
Skinvisible Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250352559-A1 | Transdermal delivery composition for delivery of at least one glucose controlling agent, and method of delivering at least one glucose controlling agent | Pending | 15-May-2024 | ||
| WO-2025240618-A2 | Transdermal delivery composition for delivery of at least one glucose controlling agent, and method of delivering at least one glucose controlling agent | Pending | 15-May-2024 | ||
| WO-2025240618-A3 | Transdermal delivery composition for delivery of at least one glucose controlling agent, and method of delivering at least one glucose controlling agent | Pending | 15-May-2024 | ||
| US-20130338198-A1 | Composition for treating dermatitis and ichthyosis, and method for treating dermatitis and ichthyosis | Inactive | 10-Dec-2010 | ||
| AU-2011338199-A1 | Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis | Inactive | 10-Dec-2010 | A61K31/401 |
Skinvisible Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Skinvisible Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Skinvisible Pharmaceuticals FAQs
-
When was Skinvisible Pharmaceuticals founded?
Skinvisible Pharmaceuticals was founded in 1998.
-
Where is Skinvisible Pharmaceuticals headquartered?
Skinvisible Pharmaceuticals is headquartered in Las Vegas, NV.
-
What is the size of Skinvisible Pharmaceuticals?
Skinvisible Pharmaceuticals has 7 total employees.
-
What industry is Skinvisible Pharmaceuticals in?
Skinvisible Pharmaceuticals’s primary industry is Other Devices and Supplies.
-
Is Skinvisible Pharmaceuticals a private or public company?
Skinvisible Pharmaceuticals is a Public company.
-
What is Skinvisible Pharmaceuticals’s stock symbol?
The ticker symbol for Skinvisible Pharmaceuticals is SKVI.
-
What is the current stock price of Skinvisible Pharmaceuticals?
As of 10-Nov-2026 the stock price of Skinvisible Pharmaceuticals is $0.18.
-
What is the current market cap of Skinvisible Pharmaceuticals?
The current market capitalization of Skinvisible Pharmaceuticals is $973K.
-
What is Skinvisible Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Skinvisible Pharmaceuticals is $20K.
-
What is Skinvisible Pharmaceuticals’s annual earnings per share (EPS)?
Skinvisible Pharmaceuticals’s EPS for 12 months was -$0.20.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
